Iran to use PastoCovac as booster dose

The CEO of the third phase of clinical trial of Iranian COVID-19 vaccine PastoCovac said that the third dose of the vaccine, named PastoCovac Plus, was authorized to be used as the booster dose for any other coronavirus vaccine.


According to Ashura News, quoted by the IRNA news agency, Epidemiologist Dr. Ehsan Mostafavi told IRNA on Tuesday that all the people who have received two shots of any type of COVID-19 vaccine, whether Sinopharm, AstraZeneca or Sputnik, can take a PastoCovac Plus jab as the booster dose.

Dr. Mostafavi said that PastoCovac Plus has been authorized to be administered to people over 12.

The vaccine has passed clinical test for children from 2 to 18 in Cuba and it is administered to children aged 12 to 18 in Iran, according to the doctor who added that younger children would be authorized to receive PastoCovac in the future.




Post a comment